3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
46
Lymphoma, Large B-Cell, Diffuse
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lung Neoplasms
21
Leukemia, Myeloid, Acute
20
Burkitt Lymphoma
18
Hodgkin Disease
15
Recurrence
14
Lymphoma, Non-Hodgkin
14
Lymphoma
14
Carcinoma, Non-Small-Cell Lung
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Neuroblastoma
10
Lymphoma, Mantle-Cell
10
Lymphoma, B-Cell
10
Leukemia
10
Medulloblastoma
8
Neoplasms, Germ Cell and Embryonal
7
Neoplasms
7
Lymphoma, Follicular
7
Multiple Myeloma
6
Lymphoma, T-Cell
6
Brain Neoplasms
6
Sarcoma, Ewing
5
Retinoblastoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Immunoblastic Lymphadenopathy
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
enasidenib
1
Tomography, X-Ray Computed
1
Radionuclide Imaging
1
Positron-Emission Tomography
1
Ibuprofen
1
Electrocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esthesioneuroblastoma, Olfactory
×
Etoposide
×
1 year
×
Clear all
No trials found.